Tratamiento personalizado del carcinoma hepatocelular basado en información molecular: perspectivas futuras
Nicolas Goossens, Yujin Hoshida – 10 November 2016
Nicolas Goossens, Yujin Hoshida – 10 November 2016
Nicolas M. Intagliata, Carlos N. Ferreira, Stephen H. Caldwell – 10 November 2016
Steven L. Flamm – 10 November 2016
Sophoclis P. Alexopoulos, Victor Nekrasov, Shu Cao, Susan Groshen, Navpreet Kaur, Yuri S. Genyk, Lea Matsuoka – 10 November 2016 – The majority of pediatric patients with end‐stage liver disease receive a transplant with a whole liver (WL) allograft. However, smaller recipients with biliary atresia (BA) may have improved outcomes with deceased donor partial liver (DDPL) or living donor allografts. This study compares the national outcomes for liver transplantation in BA, with attention to the interaction between liver allograft type and recipient size.
Elizabeth Zheng, Víctor Navarro – 10 November 2016
Guadalupe García‐Tsao – 10 November 2016
Kumiko Kitajima, Yuichi Ogawa, Katsuyuki Miki, Kotaro Kai, Akihito Sannomiya, Kazuhiro Iwadoh, Toru Murakami, Ichiro Koyama, Ichiro Nakajima, Shohei Fuchinoue – 10 November 2016 – Combined liver‐kidney transplantation (CLKT) is well established as a definitive therapy with the potential to provide complete recovery for certain liver‐kidney diseases, although the results might be contingent on the cause of transplantation.
Palittiya Sintusek, Anil Dhawan – 10 November 2016
Nataliya Razumilava, Gregory J. Gores – 10 November 2016